Verzenio 150 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,965
Award facts
- Contract value 100% obligated
- $32,965.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $32,965.24 to AmerisourceBergen Drug Corp for the supply of Verzenio 150 mg tablets (14-count unit of use packaging). This firm fixed-price delivery order, which carries a completion deadline of January 15, 2026, was awarded on a competitive basis with no set-aside designation. The contract is performed at AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's portfolio encompasses a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Verzenio is an oncology medication used in the treatment of certain breast cancers, reflecting the company's role in supplying specialized pharmaceutical products to support Defense Health Agency and other federal healthcare systems serving military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FJH8Q?
SPE2DR26FJH8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8Q worth?
The government has obligated $32,965 on SPE2DR26FJH8Q.
Is contract SPE2DR26FJH8Q an order under another contract?
Yes. SPE2DR26FJH8Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8Q competed?
The extent of competition for SPE2DR26FJH8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award